Adverse Events Reported To FDA Under MDR Program Ballooned 77% In 2006
This article was originally published in The Silver Sheet
Executive Summary
LAST YEAR'S RISE IN MEDICAL DEVICE REPORTS may have been the result of more products on the market, as well as increased compliance with reporting regulations, CDRH's Office of Surveillance and Biometrics says. More than 325,000 adverse events were reported to the agency's MDR program in calendar year 2006 - an all-time high - and OSB staffer Indira Konduri expects the trend to continue. “At some point I'm sure it will plateau, but it definitely does look like this year and next, for sure, we'll probably see an increase,” Konduri says, noting that device recalls also may have played a part in the large volume of MDRs. Meanwhile, FDA clarifies MDR reporting requirements in a warning letter to Medtronic
You may also be interested in...
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.
FDA Slaps High Risk Class I Label On Recall Of COVID-19 Diagnostics Made In Uncontrolled Plant
More than 160,000 of the tests were recalled, including 104,900 COVID Test Kits Nonsterile and 61,500 Clean Catch Urine Kits.